Global Multiple Myeloma Drugs Market 2015-2019

Global Multiple Myeloma Drugs Market 2015-2019 is the latest addition to industry research reports collection.

Multiple myeloma is a common cancer that affects the plasma cells, a type of white blood cell. It begins in the plasma cells of bone marrow. The primary function of the plasma cells is to combat infections by producing antibodies, which attack germs after recognizing them. In multiple myeloma these plasma cells become malignant, it causes the production of a defective protein, which grows uncontrollably. This protein moves into the bones and cause tumors. Myeloma occurs when the malignant cells form a tumor. According to the Multiple Myeloma Research Foundation, the disease has been classified into six distinct stages: Pain in bone, vulnerability to infections, increased restlessness, kidney and urination ailments, fatigue, increase in thirst, loss of appetite and loss in weight. The disease can be diagnosed by a series of tests. The initial evaluation consists of a blood test, urine test and a bone marrow biopsy. X-ray, MRI scan, CT- scan and PET scan are other tests to diagnose multiple myeloma. Genomic testing is also carried out to confirm the presence of multiple myeloma in the suspected patients.

Analysts forecast the Global Multiple Myeloma Drugs market to grow at a CAGR of 8.50 percent over the period 2014-2019.

Single User License of the report is Available at US $3000

This report covers the present scenario and the growth prospects of the Global Multiple Myeloma Drugs market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various generic and branded therapies used in the treatment of multiple myeloma.

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Multiple Myeloma Drugs market. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

Order a copy of this report at (Prices start at US $3000 for a single user PDF) .

Key Regions

  • • Americas

  • • APAC

  • • EMEA

Key Vendors

  • • Celgene

  • • Johnson & Johnson

  • • Novartis

  • • Onyx Pharmaceuticals

  • • Sanofi

  • • Takeda Pharmaceutical

Other Prominent Vendors

  • • AB Science

  • • Abbvie

  • • Aeterna Zentaris

  • • Amgen

  • • Bristol Myers Squibb

  • • Cephalon

  • • Daiichi Sankyo

  • • Genta

  • • Merck Sharp and Dohme

  • • Oncotherapeutics

  • • PharmaMar

  • • Teva

Market Driver

  • • Presence of Unmet Needs

Market Challenge

  • • High Cost of Treatment

Market Trend

  • • Growing Public Awareness

Key Questions Answered in this Report

  • • What will the market size be in 2019 and what will the growth rate be?

  • • What are the key market trends?

  • • What is driving this market?

  • • What are the challenges to market growth?

  • • Who are the key vendors in this market space?

  • • What are the market opportunities and threats faced by the key vendors?

  • • What are the strengths and weaknesses of the key vendors?

Have any Query on the Report get your Queries Resolved at .

Table of Contents
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Product Profiles
05. Market Research Methodology
06. Introduction
07. Disease Overview
08. Market Landscape
09. Market Segmentation by Route of Administration
10. Market Segmentation by Dosage Form
11. Geographical Segmentation
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Pipeline Portfolio
20. Vendor Landscape
21. Key Vendor Analysis
22. Other Reports in this Series

List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Pathophysiology of Multiple Myeloma
Exhibit 3: Indicators of Multiple Myeloma
Exhibit 4: Laboratory Tests to Identify Multiple Myeloma
Exhibit 5: Diagnosis of Multiple Myeloma
Exhibit 6: Staging of Multiple Myeloma
Exhibit 7: Management of Multiple Myeloma
Exhibit 8: Induction Therapy Recommendations for the Transplant Eligible Candidates
Exhibit 9: Maintenance Therapy for the Candidates with Multiple Myeloma
Exhibit 10: Supportive Therapy for the Candidates with Multiple Myeloma

About US: ( is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.